DrugDevCovid19

Tracking the relevant researches of CADD drug development against COVID-19

Meloxicam

ID MW HBD HBA
54677470  351.425
RB NOA Rings logP
4733.43

Function

DrugBank ID:

DB00814


Description:

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis.With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations. It is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy. [DrugBank]

Targets:

Prostaglandin G/H synthase 2 (Humans); Prostaglandin G/H synthase 1 (Humans) [DrugBank]

Pharmacodynamics:

Meloxicam is an anti-inflammatory, analgesic analgesic with antipyretic effects in fever.1 Prostaglandins are substances that contribute to inflammation.7 This drug also exerts preferential actions against COX-23, which may reduce the possible gastrointestinal effects of this drug. [DrugBank]

Structures

SMILES:

Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1

2D structures:  

3D structures:  

Docking in target protein

Receptor: TMPRSS2

Docking Site: Catalytic pocket

Ligand: Meloxicam

Vina score: -7.1

Off-target analysis based on ligand similarity (Homo sapiens)

Step 1 - Target prediction for Meloxicam: SwissTargetPrediction

Tips: Click on the link to jump to the 'SwissTargetPrediction' webserver. Select the species of 'Homo sapiens', and then paste the SMILES of Meloxicam in the SMILES input box.

Step 2 - Blind docking for Meloxicam: CB-Dock

Tips: Click on the link to jump to the 'CB-Dock' webserver. Upload the structure file of target predicted by 'SwissTargetPrediction' and the 2D/3D structure file of Meloxicam to perform blind docking.